{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:04:53Z","timestamp":1789769093429,"version":"4.0.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Am Acad Orthop Surg","JAAOS"],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Postoperative stiffness is a common complication after total knee arthroplasty (TKA), leading to limited range of motion (ROM), pain, and reduced function. Direct oral anticoagulants (DOACs), such as factor Xa inhibitors, are commonly prescribed for venous thromboembolism (VTE) prophylaxis but may increase the risk of postoperative stiffness due to postoperative bleeding within the knee. This study seeks to evaluate the effect of postoperative VTE prophylaxis (factor Xa inhibitors vs. aspirin) on ROM outcomes in patients undergoing TKA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A total of 1,054 patients who underwent primary TKA by the senior author between November 2021 and May 2023 were retrospectively identified from an institutional database. Records were examined at preoperative, 2-week, 6-week, &lt;1-year, and &gt;1-year postoperative visits. Logistic regression models analyzed ROM outcomes, defining success as 90\u00b0 flexion and 0\u00b0 extension at 2 weeks and 125\u00b0 flexion and 0\u00b0 extension at 6 weeks. Manipulation under anesthesia (MUA) was recorded as a secondary end point.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Factor Xa inhibitors (apixaban or rivaroxaban) did not significantly affect ROM success at 2 weeks (OR = 0.956, 95% confidence interval [CI, 0.866 to 1.054],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.364) or 6 weeks (OR = 0.986, 95% CI [0.892 to 1.089],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.778) postoperatively, compared with aspirin. VTE prophylaxis type was not found to be significantly associated with MUA likelihood.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>No association was found between postoperative ROM and VTE prophylaxis medication. Previous studies used lower ROM thresholds or focused solely on MUAs. Understanding the effects of DOACs on postoperative stiffness can help guide chemoprophylaxis decisions after TKA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5435\/jaaos-d-25-00421","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T21:00:09Z","timestamp":1769547609000},"page":"e2764-e2770","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Effect of Postoperative Medication on Range of Motion After Total Knee Arthroplasty: An Evaluation of Venous Thromboembolism Chemoprophylaxis"],"prefix":"10.5435","volume":"34","author":[{"given":"Katelyn L.","family":"Kirwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant J.","family":"Dornan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1637-3163","authenticated-orcid":false,"given":"Alexa N.","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bret M.","family":"Hatzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine V.","family":"Hartman Budnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Kuppersmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"R1-20260918","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.knee.2005.10.001","article-title":"Stiffness after total knee arthroplasty: Prevalence, management and outcomes","volume":"13","author":"Yercan","year":"2006","journal-title":"Knee"},{"key":"R2-20260918","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1007\/s00264-021-05023-3","article-title":"Causes of stiffness after total knee arthroplasty: A systematic review","volume":"45","author":"Zaffagnini","year":"2021","journal-title":"Int Orthop"},{"key":"R3-20260918","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1016\/j.arth.2017.02.005","article-title":"Arthrofibrosis associated with total knee arthroplasty","volume":"32","author":"Cheuy","year":"2017","journal-title":"J Arthroplasty"},{"issue":"1","key":"R4-20260918","article-title":"Increased risk of stiffness following total knee arthroplasty with direct oral anticoagulants and avoidance of selective COX-2 inhibitors","volume":"4","author":"Frederick","year":"2023","journal-title":"J Orthop Exp Innov"},{"key":"R5-20260918","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1054\/arth.2002.32105","article-title":"Revision of the stiff total knee arthroplasty","volume":"17","author":"Christensen","year":"2002","journal-title":"J Arthroplasty"},{"key":"R6-20260918","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.arth.2005.06.004","article-title":"Predictive risk factors for stiff knees in total knee arthroplasty","volume":"21","author":"Gandhi","year":"2006","journal-title":"J Arthroplasty"},{"key":"R7-20260918","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.knee.2004.06.004","article-title":"Arthrofibrosis following total knee replacement; does therapeutic warfarin make a difference?","volume":"12","author":"Walton","year":"2005","journal-title":"Knee"},{"issue":"suppl 1","key":"R8-20260918","first-page":"264","article-title":"Stiffness after total knee arthroplasty","volume":"87","author":"Nelson","year":"2005","journal-title":"J Bone Joint Surg Am"},{"key":"R9-20260918","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13018-020-1555-5","article-title":"Angiotensin II blockade had no effect on range of motion after total knee arthroplasty: A retrospective review","volume":"15","author":"Langston","year":"2020","journal-title":"J Orthop Surg Res"},{"key":"R10-20260918","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.2106\/JBJS.17.01110","article-title":"Type of anticoagulant used after total knee arthroplasty affects the rate of knee manipulation for postoperative stiffness","volume":"100","author":"Kahlenberg","year":"2018","journal-title":"J Bone Joint Surg Am"},{"key":"R11-20260918","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12306-018-0537-9","article-title":"Manipulation under anesthesia following total knee arthroplasty: A comprehensive review of literature","volume":"102","author":"Kornuijt","year":"2018","journal-title":"Musculoskelet Surg"},{"key":"R12-20260918","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1054\/arth.2003.50024","article-title":"The effect of anticoagulation on the restoration of range of motion after total knee arthroplasty: Enoxaparin versus aspirin","volume":"18","author":"Keays","year":"2003","journal-title":"J Arthroplasty"},{"key":"R13-20260918","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.arth.2017.08.039","article-title":"Increased incidence of bleeding and wound complications with Factor-Xa inhibitors after total joint arthroplasty","volume":"33","author":"Garfinkel","year":"2018","journal-title":"J Arthroplasty"},{"key":"R14-20260918","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jor.2017.08.002","article-title":"Comparison of postoperative complications after total hip arthroplasty among patients receiving aspirin, enoxaparin, warfarin, and factor Xa inhibitors","volume":"14","author":"Agaba","year":"2017","journal-title":"J Orthop"},{"key":"R15-20260918","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.2106\/JBJS.K.00521","article-title":"Wound complications following rivaroxaban administration: A multicenter comparison with low-molecular-weight heparins for thromboprophylaxis in lower limb arthroplasty","volume":"94","author":"Jameson","year":"2012","journal-title":"J Bone Joint Surg Am"},{"key":"R16-20260918","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00590-012-0987-y","article-title":"Elective hip and knee arthroplasty and the effect of rivaroxaban and enoxaparin thromboprophylaxis on wound healing","volume":"23","author":"Sindali","year":"2013","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"R17-20260918","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/phar.1888","article-title":"Retrospective evaluation of postoperative adverse drug events in patients receiving rivaroxaban after major orthopedic surgery compared with standard therapy in a community hospital","volume":"37","author":"Cieri","year":"2017","journal-title":"Pharmacotherapy"},{"key":"R18-20260918","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.arth.2016.04.004","article-title":"Aspirin as thromboprophylaxis in hip and knee arthroplasty: A systematic review and meta-analysis","volume":"31","author":"An","year":"2016","journal-title":"J Arthroplasty"},{"key":"R19-20260918","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.artd.2021.06.015","article-title":"Time for an update? A look at current guidelines for venous thromboembolism prophylaxis after hip and knee arthroplasty and hip fracture","volume":"10","author":"Muscatelli","year":"2021","journal-title":"Arthroplasty Today"},{"key":"R21-20260918","doi-asserted-by":"crossref","first-page":"570","DOI":"10.32614\/RJ-2021-053","article-title":"Reproducible summary tables with the gtsummary package","volume":"13","author":"Sjoberg","year":"2021","journal-title":"R J"},{"key":"R22-20260918","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/1753944715605011","article-title":"Factor Xa inhibitors: A novel therapeutic class for the treatment of nonvalvular atrial fibrillation","volume":"10","author":"McCarty","year":"2016","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"R23-20260918","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.thromres.2010.09.008","article-title":"The mechanism of action of rivaroxaban\u2014An oral, direct factor Xa inhibitor\u2014Compared with other anticoagulants","volume":"127","author":"Samama","year":"2011","journal-title":"Thromb Res"},{"key":"R24-20260918","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.arthro.2020.09.019","article-title":"Pharmacologic thromboprophylaxis other than aspirin is associated with increased risk for procedural intervention for arthrofibrosis after anterior cruciate ligament reconstruction","volume":"37","author":"Qin","year":"2021","journal-title":"Arthrosc J"},{"key":"R25-20260918","doi-asserted-by":"crossref","first-page":"574","DOI":"10.5435\/JAAOS-D-20-01358","article-title":"Anticoagulant usage after anterior cruciate ligament reconstruction is associated with increased rate of manipulation under anesthesia","volume":"31","author":"Gu","year":"2023","journal-title":"J Am Acad Orthop Surg"},{"key":"R26-20260918","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.arth.2022.01.008","article-title":"Aspirin administered for venous thromboembolism prophylaxis may protect against stiffness following total knee arthroplasty","volume":"37","author":"Shohat","year":"2022","journal-title":"J Arthroplasty"},{"key":"R27-20260918","doi-asserted-by":"crossref","first-page":"S350","DOI":"10.1016\/j.arth.2023.03.076","article-title":"Nonsteroidal anti-inflammatory drugs and oral corticosteroids mitigated the risk of arthrofibrosis after total knee arthroplasty","volume":"38","author":"Salmons","year":"2023","journal-title":"J Arthroplasty"},{"key":"R28-20260918","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1002\/jor.24441","article-title":"Inhibition of COX-2 pathway as a potential prophylaxis against arthrofibrogenesis in a rabbit model of joint contracture","volume":"37","author":"Salib","year":"2019","journal-title":"J Orthop Res"},{"key":"R29-20260918","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1302\/2046-3758.111.BJR-2021-0546.R1","article-title":"Intra-articular celecoxib improves knee extension regardless of surgical release in a rabbit model of arthrofibrosis","volume":"11","author":"Trousdale","year":"2022","journal-title":"Bone Joint Res"},{"key":"R30-20260918","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1002\/jor.24647","article-title":"Reduction of arthrofibrosis utilizing a collagen membrane drug-eluting scaffold with celecoxib and subcutaneous injections with ketotifen","volume":"38","author":"Limberg","year":"2020","journal-title":"J Orthop Res"},{"key":"R31-20260918","doi-asserted-by":"crossref","first-page":"S1010","DOI":"10.1016\/j.arth.2022.03.026","article-title":"Perioperative use of antifibrotic medications associated with lower rate of manipulation after primary TKA: An analysis of 101,366 patients","volume":"37","author":"Premkumar","year":"2022","journal-title":"J Arthroplasty"},{"key":"R32-20260918","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.arth.2011.04.007","article-title":"Benefits of prolonged postoperative Cyclooxygenase-2 inhibitor administration on total knee arthroplasty recovery: A double-blind, placebo-controlled study","volume":"26","author":"Schroer","year":"2011","journal-title":"J Arthroplasty"},{"key":"R33-20260918","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ocl.2012.07.001","article-title":"Is socioeconomic status a risk factor for stiffness after total knee arthroplasty? A multicenter case-control study","volume":"43","author":"Springer","year":"2012","journal-title":"Orthop Clin North Am"}],"container-title":["Journal of the American Academy of Orthopaedic Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-25-00421","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:00:13Z","timestamp":1789768813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-25-00421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":32,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5435\/jaaos-d-25-00421","relation":{},"ISSN":["1067-151X","1940-5480"],"issn-type":[{"value":"1067-151X","type":"print"},{"value":"1940-5480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"2025-04-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}